RxDoctor Payments DataLook up a doctor →

Ralph Duda

Endocrinology, Diabetes & Metabolism · Springfield, MONPI 1356436406

Payments from drug & device makers

$3,045,475in general payments, 2019–2025

Across 1,200 payments — averaging $2537.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2M
  • Lilly USA, LLC$511K
  • Boehringer Ingelheim$149K
  • AbbVie$98K
  • Regeneron$79K
  • Novo Nordisk$78K
  • plus $169K from 12 others
$44,029in research payments, 2019–2025

Across 3 payments — averaging $14,676 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$44K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,045,475 in reported general payments places this provider in the 95th percentile of 182 endocrinology, diabetes & metabolism providers in Missouri.

See all endocrinology, diabetes & metabolism providers in Missouri

Other endocrinology, diabetes & metabolism in Springfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →